Total Funding
61
37
Total FundingSeries B raised
Growth Score
-3 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
43709
R3 Vascular is a medical device company that develops new therapies to treat peripheral artery disease.
- Kamal Ramzipoor: President and CEOPast Role: Amaranth Medical, General Manager and Chief Technical Officer
Christopher M. Owens: President and CEOPast Role: IDEV Technologies, President and CEO
About the Company
R3 Vascular creates bioresorbable scaffold technology with a sirolimus coating for the treatment of peripheral arterial disease. R3 Vascular's polymer and proprietary technologies are used to create scaffolds that balance strength and flexibility for the treatment of peripheral arterial disease. The magnitude BRS device is the thinnest BRS
ever tested in this clinical setting, with a strut thickness of 98 microns across its entire usable range of diameters.
